Clinical Trials - September 30, 2024
Cereno signs agreement with Fluidda and announces Phase IIa results
Cereno Scientific has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting.
Biotech Business - September 27, 2024
Evaxion expands vaccine development collaboration
Evaxion Biotech has entered into an option and license agreement with MSD for two preclinical vaccine candidates.
Collaboration - September 25, 2024
Ribo and Pheiron enter strategic collaboration for AI-assisted drug development
Ribocure Pharmaceuticals and Suzhou Ribo Life Science have entered a partnership with Pheiron to leverage its AI platform in Ribo’s discovery and development of RNA-based therapeutics.
Collaboration - September 16, 2024
We are launching a new site!
We are happy to announce that we will be launching our updated and improved website this week, 16-22 September!
Collaboration - September 14, 2024
Are you ready for Nordic Life Science Days 2024?
The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.
Collaboration - September 14, 2024
New report: Recommendations to strengthen Nordic co-operation
In the report Nordic added value in inter-ministerial Nordic co-operation, funded through NordForsk by the Nordic Council of Ministers, the researchers present six recommendations to optimize the use of the concept of ‘Nordic added value’ across Nordic institutions.
